Opportunity Information: Apply for CDC RFA IP16 1605
Maintenance of Influenza Surveillance Capacity by National Health Authorities Outside the United States (CDC RFA IP16-1605) is a CDC cooperative agreement designed to help selected countries sustain and institutionalize the influenza surveillance capabilities they built or strengthened with earlier CDC support. The program sits within CDCs broader decade-long effort to improve global pandemic readiness across three core areas: preparedness and communication, surveillance and detection, and response and containment. Rather than launching surveillance from scratch, this opportunity focuses on maintaining momentum and ensuring that influenza monitoring systems become routine, reliable parts of national public health infrastructure.
The main goal is to keep influenza surveillance networks functioning at a high level while countries transition toward full national ownership. Participating ministries of health are expected to develop detailed, realistic plans to assume the operational and financial responsibility for ongoing surveillance. The surveillance systems supported under this award are meant to cover seasonal influenza as well as novel and potentially pandemic strains, with an emphasis on being able to detect unusual events quickly, characterize them virologically and epidemiologically, and trigger an appropriate public health response. At the same time, the program expects countries to generate data that can be used to understand when and where influenza is circulating, which populations are most affected, and what the overall health impact looks like within the country.
A strong laboratory component is central to the opportunity. Countries receiving funding must maintain or continue making measurable progress toward having an active World Health Organization National Influenza Center (NIC). They are also expected to contribute specimens, data, and other relevant outputs on a regular basis to the global influenza system, referenced in the announcement as the Global Influenza Surveillance Network (GISN). In practice, that expectation ties national surveillance work to global situational awareness, improving the ability to track evolving influenza viruses and informing international risk assessment and preparedness activities.
While the announcement encourages a focus on severe respiratory disease surveillance capacity, it does not require that approach exclusively. The intent is to strengthen the ability to monitor and investigate more serious outcomes alongside broader influenza activity, supporting earlier warning of severe or unusual patterns and improving the evidence base for response decisions. Overall, the expectation is that countries will operate robust, timely, and routine systems that can both support day-to-day seasonal influenza monitoring and pivot quickly during an emerging pandemic threat.
A defining feature of the award is the built-in transition away from US government financing. Each recipient must develop and implement a phase-out plan that reduces reliance on US funding over the five-year project period, with the end state being a domestically supported and managed influenza surveillance program. This requirement makes sustainability a formal deliverable rather than an informal aspiration, pushing planning around budgets, staffing, procurement, training, and national policy commitments.
Eligibility is limited to ministries of health (or their bona fide agents) in a specific set of countries that previously received CDC support under earlier influenza-related funding opportunity announcements (IP10-1001, IP11-1103, and GH14-1408). The eligible locations listed are Afghanistan, Armenia, Bangladesh, Brazil, Cambodia, China, Cote dIvoire, Democratic Republic of Congo, Ethiopia, Indonesia, Laos, Mexico, Mongolia, Morocco, Nigeria, Pakistan, Peru, Philippines, Republic of Georgia, Russia, Rwanda, Secretariat of the Pacific Community (SPC), South Africa, Tanzania, Uganda, Ukraine, and Vietnam. The opportunity is administered by the CDCs National Center for Immunization and Respiratory Diseases (NCIRD), uses a cooperative agreement mechanism (indicating substantial CDC involvement and collaboration during implementation), and was expected to make 27 awards. The original closing date for applications was July 18, 2016, and the CFDA listing associated with the program is 93.318.Apply for CDC RFA IP16 1605
- The Centers for Disease Control - NCIRD in the health sector is offering a public funding opportunity titled "Maintenance of Influenza Surveillance Capacity by National Health Authorities Outside the United States." and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.318.
- This funding opportunity was created on 2016-05-18.
- Applicants must submit their applications by 2016-07-18. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 27 candidate(s).
- Eligible applicants include: Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is CDC RFA IP16-1605?
CDC RFA IP16-1605, titled "Maintenance of Influenza Surveillance Capacity by National Health Authorities Outside the United States," is a CDC cooperative agreement that supports selected countries in sustaining and institutionalizing influenza surveillance capabilities built or strengthened through earlier CDC support.
What is the main purpose of this opportunity?
The main purpose is to keep national influenza surveillance networks functioning at a high level while countries transition toward full national ownership. The award emphasizes maintaining momentum rather than starting new systems from scratch, so that influenza monitoring becomes a routine and reliable part of national public health infrastructure.
How does this program fit into CDCs broader global health work?
This opportunity sits within CDCs broader decade-long effort to improve global pandemic readiness across three core areas: preparedness and communication, surveillance and detection, and response and containment.
Is this grant meant to create new influenza surveillance systems?
No. The focus is on maintaining and institutionalizing surveillance capacity that was previously built or strengthened with earlier CDC support, not launching surveillance programs from scratch.
What outcomes are participating ministries of health expected to achieve?
Participating ministries of health are expected to develop detailed, realistic plans to assume operational and financial responsibility for ongoing surveillance, and to operate surveillance systems that are routine, timely, robust, and able to support both seasonal influenza monitoring and rapid pivoting during an emerging pandemic threat.
What types of influenza are included in the surveillance expectations?
The surveillance systems supported under this award are intended to cover both seasonal influenza and novel and potentially pandemic strains. A key expectation is the ability to detect unusual events quickly, characterize them virologically and epidemiologically, and trigger an appropriate public health response.
What kinds of information should the surveillance systems produce?
The program expects countries to generate data that can be used to understand when and where influenza is circulating, which populations are most affected, and what the overall health impact looks like within the country.
Is severe respiratory disease surveillance required?
The announcement encourages a focus on severe respiratory disease surveillance capacity, but it does not require that approach exclusively. The intent is to strengthen the ability to monitor and investigate more serious outcomes alongside broader influenza activity.
What role do laboratories play in this award?
A strong laboratory component is central. Countries receiving funding must maintain or continue making measurable progress toward having an active World Health Organization National Influenza Center (NIC).
What is expected regarding the World Health Organization National Influenza Center (NIC)?
Recipients must maintain or continue making measurable progress toward having an active WHO National Influenza Center (NIC), reflecting the expectation of sustained national laboratory capability for influenza.
What is GISN, and what are recipients expected to do related to it?
The announcement references the Global Influenza Surveillance Network (GISN) as the global influenza system. Recipients are expected to contribute specimens, data, and other relevant outputs to this system on a regular basis, linking national surveillance to global situational awareness and international risk assessment and preparedness.
Does CDC have an active role during implementation?
Yes. The award uses a cooperative agreement mechanism, which indicates substantial CDC involvement and collaboration during implementation.
What is the sustainability or phase-out requirement?
A defining feature is a required transition away from US government financing. Each recipient must develop and implement a phase-out plan over the five-year project period that reduces reliance on US funding, with the end state being a domestically supported and managed influenza surveillance program.
What does "transition to national ownership" mean in this program?
In this program, it means ministries of health are expected to move toward assuming both operational and financial responsibility for influenza surveillance, including planning around budgets, staffing, procurement, training, and national policy commitments, so the system can continue without US government financing.
How long is the project period for the phase-out plan?
The phase-out plan is expected to reduce reliance on US funding over a five-year project period.
Who is eligible to apply?
Eligibility is limited to ministries of health (or their bona fide agents) in specific countries that previously received CDC support under earlier influenza-related funding opportunity announcements (IP10-1001, IP11-1103, and GH14-1408).
Which countries and entities are listed as eligible locations?
The eligible locations listed are Afghanistan, Armenia, Bangladesh, Brazil, Cambodia, China, Cote dIvoire, Democratic Republic of Congo, Ethiopia, Indonesia, Laos, Mexico, Mongolia, Morocco, Nigeria, Pakistan, Peru, Philippines, Republic of Georgia, Russia, Rwanda, Secretariat of the Pacific Community (SPC), South Africa, Tanzania, Uganda, Ukraine, and Vietnam.
What does "bona fide agents" mean in the eligibility statement?
The announcement indicates ministries of health may apply directly or through their bona fide agents. Based on the text provided, this refers to entities acting on behalf of the ministry of health, as permitted by the eligibility rules described.
How many awards were expected under this opportunity?
The opportunity was expected to make 27 awards.
Which CDC center administers this opportunity?
The opportunity is administered by CDCs National Center for Immunization and Respiratory Diseases (NCIRD).
What is the application deadline mentioned in the announcement?
The original closing date for applications was July 18, 2016.
What is the CFDA number associated with this program?
The CFDA listing associated with the program is 93.318.
What is the overall emphasis of the surveillance systems supported?
The overall emphasis is on robust, timely, and routine systems that support day-to-day seasonal influenza monitoring, can rapidly detect and characterize unusual events, and can pivot quickly during an emerging pandemic threat, while also contributing to global influenza situational awareness through regular sharing of specimens and data.
Browse more opportunities from the same category: Health
Next opportunity: Drug Demand Reduction Services for Rural Communities
Previous opportunity: FY24 Dr. Nancy Foster Scholarship Program
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA IP16 1605
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA IP16 1605) also looked into and applied for these:
| Funding Opportunity |
|---|
| Announcement of Availability of Funds for a Training and Technical Assistance Project to Support the Title X Family Planning Program Apply for PA FPT 16 002 Funding Number: PA FPT 16 002 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $4,000,000 |
| PPHF 2015: Immunization Grants-CDC Partnership: Strengthening Public Health Laboratories-financed in part by 2015 Prevention and Public Health Funds Apply for CDC RFA OE 15010201SUPP16 Funding Number: CDC RFA OE 15010201SUPP16 Agency: Centers for Disease Control - CSELS Category: Health Funding Amount: Case Dependent |
| Comprehensive asthma control through evidence-based strategies and public health - health care collaboration Apply for CDC RFA EH16 1606 Funding Number: CDC RFA EH16 1606 Agency: Centers for Disease Control - NCEH Category: Health Funding Amount: $500,000 |
| PPHF 2016: PPHF Epidemiology and Laboratory Capacity Program – US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-associated Hospitalizations – financed in part by 2016 Prevention and Public Heal Apply for RFA IP 15 00202CONTPPHF16 Funding Number: RFA IP 15 00202CONTPPHF16 Agency: Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: Case Dependent |
| PPHF 2016: Immunization Grants - Immunization and Vaccines for Children Program – Financed in Part by 2016 Prevention and Public Health Funds Apply for CDC RFA IP13 13010401SUPPPPHF16 Funding Number: CDC RFA IP13 13010401SUPPPPHF16 Agency: Centers for Disease Control - NCIRD Category: Health Funding Amount: Case Dependent |
| Prescription Drug Overdose Prevention for States Program Supplement Apply for CDC RFA CE15 15010201SUPP16 Funding Number: CDC RFA CE15 15010201SUPP16 Agency: Centers for Disease Control - NCIPC Category: Health Funding Amount: $1,000,000 |
| Improving Effectiveness of the Tuberculosis Prevention and Control Programs in Resource Limited Countries Apply for CDC RFA PS14 1411A Funding Number: CDC RFA PS14 1411A Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| PPHF 2016: Immunization Grants - Enhanced Surveillance for New Vaccine Preventable Diseases - Financed Apply for RFA IP 16 004PPHF16 Funding Number: RFA IP 16 004PPHF16 Agency: Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: Case Dependent |
| National HIV Behavioral Surveillance (NHBS) Apply for CDC RFA PS16 160102CONT17 Funding Number: CDC RFA PS16 160102CONT17 Agency: Centers for Disease Control - NCHHSTP Category: Health Funding Amount: Case Dependent |
| The Health Insurance Enforcement and Consumer Protections Grant Program Apply for PR PRP 17 001 Funding Number: PR PRP 17 001 Agency: CMS-Consumer Information Insurance Oversight Category: Health Funding Amount: Case Dependent |
| Global Emergency Response and Recovery Partner Engagement: Expanding Efforts and Strategies to Improve Rapid Response to Public Health Emergencies Globally Apply for CDC RFA GH16 1719 Funding Number: CDC RFA GH16 1719 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Technical Assistance to National Health Information Systems and Health Workforce Development of the Federal Democratic Republic of Ethiopia under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1749 Funding Number: CDC RFA GH17 1749 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: $2,750,000 |
| Integrated Delivery of HIV Services in Sexual and Reproductive Health Clinics Targeting Key and Priority Populations and in Confidential STI Clinics for Commercial Sex Workers in Ethiopia under PEPFAR Apply for CDC RFA GH17 1743 Funding Number: CDC RFA GH17 1743 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: $2,250,000 |
| Implementation of Programs for the Prevention, Care and Treatment of HIV/AIDS in the Republic of Cote d'Ivoire under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1756 Funding Number: CDC RFA GH17 1756 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: $13,000,000 |
| Technical Assistance to India's National AIDS Control Program (NACP) for Strengthening Adult and Pediatric Anti-retroviral Treatment (ART) and Care Services Delivery Network under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1713 Funding Number: CDC RFA GH17 1713 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: $1,000,000 |
| Provision of Comprehensive Community Based Care and Support for People Living with HIV (PLHIV) in the United Republic of Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1720 Funding Number: CDC RFA GH17 1720 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: $9,000,000 |
| Accelerating Epidemic Control in Kampala Region in the Republic of Uganda under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1707 Funding Number: CDC RFA GH17 1707 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: $28,612,344 |
| Transforming HIV Patient Care in Sub Saharan Africa to Support the 90-90-90 Goals under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1775 Funding Number: CDC RFA GH17 1775 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: $2,400,000 |
| Strengthening National Capacity for Integrated HIV/AIDS Health Data Collection, Use, and Dissemination in Support of an Evidence-based Response in South Sudan under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1765 Funding Number: CDC RFA GH17 1765 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: $3,500,000 |
| Strengthening Public Health Laboratory Systems in the Republic of Cameroon under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1719 Funding Number: CDC RFA GH17 1719 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: $5,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA IP16 1605", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.